Dr Paul Huang is a Team Leader in the Division of Molecular Pathology at the Institute of Cancer Research (ICR). He received his PhD from Massachusetts Institute of Technology (MIT) in Biological Engineering (2008) and started his laboratory at the ICR as an Institute Fellow in 2009 where he held a Sir Henry Wellcome Fellowship. He is currently a tenured Career Faculty and holds a Cancer Research UK Career Establishment Award.
Dr Huang also serves as a member of several panels including the NCRI Cellular Molecular Pathology (CM-Path) Clinical Trial Pathology Advisory Group (CT-PAG) and the Scientific Evaluation Committee of the European Research Area Network (ERA-NET) TRANSCAN-2 for joint translational cancer research.
His research focuses on the use of systems biology and molecular pathology strategies to understand aberrant signalling networks and drug resistance in sarcomas and lung cancer, with the goal of developing biomarkers and new therapies for these diseases.